Antimicrobial and Cytotoxic Activity of Novel Imidazolium-Based Ionic Liquids

Molecules. 2022 Mar 18;27(6):1974. doi: 10.3390/molecules27061974.

Abstract

In this study, a series of 10 novel 1-methyl-3-octyloxymethylimidazolium derivatives carrying various anionic moieties (4-hydroxybenzenesulfonate, benzenesulfonate, carvacroloxyacetate, chloride, formate, propionate, thymoloxyacetate, vanillinoxyacetate, eugenoloxyacetate and trimethylacetate) were synthesized. Compounds were tested for their antimicrobial activity against six microbe strains (Staph-ylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Enterococcus faecalis, and Candida albicans), cytotoxic activity against the mouse melanoma cell line (B16 F10), and surface active properties. All synthesized compounds exhibited antimicrobial activity (expressed as minimum inhibitory concentration; in range of 0.10-27.82 mM/L), especially against Gram-positive bacteria and fungi. In addition, all compounds demonstrated cytotoxicity on B16 F10 cells (IC50 values 0.0101-0.0197 mM/L). Surface properties defined as CMC values, ranged from 0.72 to 32.35 mmol L-1. The obtained results provide an insight into the promising activity of a novel group of quaternary imidazolium derivatives having ionic liquid properties. The most potent compounds, containing a thymoloxyacetate and eugenoloxyacetate moiety, could be candidates for new antimicrobial agents or surfactants.

Keywords: antimicrobial properties; cytotoxicity; imidazolium compounds; ionic liquids.

MeSH terms

  • Animals
  • Anti-Infective Agents* / pharmacology
  • Candida albicans
  • Gram-Negative Bacteria
  • Gram-Positive Bacteria
  • Ionic Liquids* / pharmacology
  • Mice

Substances

  • Anti-Infective Agents
  • Ionic Liquids